Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging

References

• Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation66(6), 1146–1149 (1982).
   PubMed Web of Science ®Google Scholar
• Conti CR. The stunned and hibernating myocardium: a brief review. Clin. Cardiol.14(9), 708–712 (1991).
   Google Scholar
• Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the ‘hibernating myocardium’. J. Am. Coll. Cardiol.8(6), 1467–1470 (1986).
   PubMed Web of Science ®Google Scholar
• Kaul S. There may be more to myocardial viability than meets the eye. Circulation92(10), 2790–2793 (1995).
   Google Scholar
• Chareonthaitawee P, Gersh BJ, Araoz PA, Gibbons RJ. Revascularization in severe left ventricular dysfunction: the role of viability testing. J. Am. Coll. Cardiol.46(4), 567–574 (2005).
   PubMed Web of Science ®Google Scholar
• Velazquez EJ, Lee KL, Deja MA, Jain A et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N. Engl. J. Med.364(17), 1607–1616 (2011).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Maurer G, Lee KL et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N. Engl. J. Med.364, 1617–1625 (2011).
   PubMed Web of Science ®Google Scholar
• Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol.39(7), 1151–1158 (2002).
   PubMed Web of Science ®Google Scholar
• Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J. Am. Coll. Cardiol.33(7), 1848–1854 (1999).
   PubMed Web of Science ®Google Scholar
• Nesto RW, Kowalchuk MD. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expression of ischemia. Am. J. Cardiol.59(7), 23C–30C (1987).
   PubMed Web of Science ®Google Scholar
• Schinkel AFL, Bax JJ, Poldermans D et al. Noninvasive evaluation if ischemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur. Heart J.24(9), 789–800 (2003).
   Google Scholar
• Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation103(21), 2566–2571 (2001).
   PubMed Web of Science ®Google Scholar
• Berman DS, Hachamovitch R, Shaw LJ et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. J. Nucl. Med.47(1), 74–82 (2006).
   Google Scholar
• Berman DS, Hachamovitch R, Shaw LJ et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease. J. Nucl. Med.47(7), 1107–1118 (2006).
   PubMed Web of Science ®Google Scholar
• Vogel-Claussen J, Rochitte CE, Wu KC et al. Delayed enhancement MR imaging: utility in myocardial assessment. Radio Graphics26(3), 795–810 (2006).
   Google Scholar
• Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J. Am. Soc. Echocardiogr.20(9), 1021–1041 (2007).
   PubMed Web of Science ®Google Scholar
• Ryan T, Feigenbaum H. Exercise echocardiography. Am. J. Cardiol.69(20), 82H–89H (1992).
   Web of Science ®Google Scholar
• Hayes JT, Mahmarian JJ, Cochran AJ et al. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J. Am. Coll. Cardiol.21(7), 1583–1590 (1993).
   Google Scholar
• O’Sullivan CA, Duncan A, Daly C, Li W, Oldershaw P, Henein MY. Dobutamine stress-induced ischemic right ventricular dysfunction and its relation to cardiac output in patients with three-vessel coronary artery disease with angina-like symptoms. Am. J. Cardiol.96(5), 622–627 (2005).
   Google Scholar
• Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann. Intern. Med.130(9), 719–728 (1999).
   PubMed Web of Science ®Google Scholar
• Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA280(10), 913–920 (1998).
   PubMed Web of Science ®Google Scholar
• Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH. Incremental benefit of myocardial contrast to combined dipyidamole – exercise stress echocardiography for the assessment of coronary artery disease. Circulation110, 1108–1113 (2004).
   PubMed Web of Science ®Google Scholar
• Douglas PS, Bijoy Khandheria B, Raymond F et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress ehocardiography. J. Am. Coll. Cardiol.51(11), 1127–1147 (2008).
   PubMed Web of Science ®Google Scholar
• Brown KA. Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease? Am. J. Cardiol.81(8), 1050–1053 (1998).
   Google Scholar
• La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J. Am. Coll. Cardiol.23(3), 617–626 (1994).
   Google Scholar
• Cornel JH, Bax JJ, Elhendy A et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implication of time course of recovery on diagnostic accuracy. J. Am. Coll. Cardiol.31(5), 1002–1010 (1998).
   Web of Science ®Google Scholar
• Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J. Am. Coll. Cardiol.32(4), 921–926 (1998).
   Web of Science ®Google Scholar
• Nagueh SF, Vaduganathan P, Ali N et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J. Am. Coll. Cardiol.29(5), 985–993 (1997).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr. Probl. Cardiol.26(2), 147–186 (2001).
   PubMed Web of Science ®Google Scholar
• Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation103(21), 2560–2565 (2001).
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Haiden M, Kamihata H, Nishiue T, Iwasaka T. Usefulness of strain rate imaging in detecting ischemic myocardium during dobutamine stress. Int. J. Cardiol.102(2), 225–231 (2005).
   PubMed Web of Science ®Google Scholar
• Bansal M, Jeffriess L, Leano R, Mundy J, Marwick TH. Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking. JACC Cardiovasc. Imaging3(2), 121–131 (2010).
   PubMed Web of Science ®Google Scholar
• Thibault H, Derumeaux G. Assessment of myocardial ischemia and viability using tissue Doppler and deformation imaging: the lessons from the experimental studies. Arch. Cardiovasc. Dis.101(1), 61–68 (2008).
   Google Scholar
• Cuocolo A, Acampa W, Imbriaco M, De Luca N, Iovino GL, Salvatore M. The many ways to myocardial perfusion imaging. Q. J. Nucl. Med. Mol. Imaging49(1), 4–18 (2005).
   PubMed Web of Science ®Google Scholar
• Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ. Cardiovasc. Imaging2(5), 412–424 (2009).
   PubMed Web of Science ®Google Scholar
• Underwood SR, Bax JJ, Dahl VJ et al. Imaging techniques for the assessment of myocardial hibernation. Eur. Heart J.25(10), 815–836 (2004).
   Google Scholar
• Kapur A, Latus KA, Davies G et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur. J. Nucl. Med. Mol. Imaging29(12), 1608–1616 (2002).
   Web of Science ®Google Scholar
• Nielsen AP, Morris KG, Murdock R et al. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation61(4), 797–801 (1980).
   PubMed Web of Science ®Google Scholar
• Beller GA, Watson DD, Ackell P, Pohost GM. Time course of thallium-201 redistribution after transient myocardial ischemia. Circulation61(4), 791–797 (1980).
   Google Scholar
• Udelson JE, Coleman PS, Metherall J et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201-Tl and 99m Tc-sestamibi. Circulation89(6), 2552–2561 (1994).
   PubMed Web of Science ®Google Scholar
• Vaduganathan P, He ZX, Raghavan C et al. Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging? J. Am. Coll. Cardiol.28(3), 543–550 (1996).
   Google Scholar
• Yao SS, Rozanski A. Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease. Prog. Cardiovasc. Dis.43(4), 281–302 (2001).
   Google Scholar
• Sciagrà R, Pellegri M, Pupi A et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J. Am. Coll. Cardiol.36(3), 739–745 (2000).
   Google Scholar
• He W, Acampa W, Mainolfi C et al. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. J. Nucl. Cardiol.10(6), 599–606 (2003).
   Web of Science ®Google Scholar
• Abidov A, Bax JJ, Hayes SW et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J. Am. Coll. Cardiol.42(10), 1818–1825 (2003).
   Web of Science ®Google Scholar
• Duvall WL, Wijetunga MN, Kelin TM et al. The prognosis of a normal stress-only Tc-99m myocardial perfusion imaging study. J. Nucl. Cardiol.17(3), 370–377 (2010).
   Google Scholar
• Slomka PJ, Patton JA, Berman DS et al. Advances in technical aspects of myocardial perfusion SPECT imaging. J. Nucl. Cardiol.16(2), 255–276 (2009).
   PubMed Web of Science ®Google Scholar
• Maddahi J, Kiat H, Friedman JD, Berman DS, Van Train KF, Garcia EV. Technetium-99m-sestamibi myocardial perfusion imaging for evaluation of coronary artery disease. In: Nuclear Cardiology: State of the Art and Future Directions (1st Edition). Zaret BL, Beller GA (Eds). Mosby-Year Book, St Louis, MO, USA, 191–200 (1993).
   Google Scholar
• Shaw LJ, Berman DS, Maron DJ et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation117(10), 1283–1291 (2008).
   PubMed Web of Science ®Google Scholar
• Mahmarian JJ, Shaw LJ, Filipchuk NG et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J. Am. Coll. Cardiol.48(12), 2448–2457 (2006).
   PubMed Web of Science ®Google Scholar
• Druz RS. Current advances in vasodilator pharmacological stress perfusion imaging. Semin. Nucl. Med.39(3), 204–209 (2009).
   Google Scholar
• McClellan J, Travin M, Herman S et al. Prognostic importance of scintigraphic left ventricular cavity dilatation during intravenous dipyridamole technetiun-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am. J. Cardiol.79(5), 600–605 (1997).
   Google Scholar
• Hendel RC, Berman DS, Di Carli et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging. Circulation119(22), e561–e587 (2009).
   PubMed Web of Science ®Google Scholar
• Marzullo P, Parodi O, Reisenhofer B et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am. J. Cardiol.71(2), 166–172 (1993).
   PubMed Web of Science ®Google Scholar
• Beanlands RS, Nichol G, Huszti E et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J. Am. Coll. Cardiol.50(20), 2002–2012 (2007).
   PubMedGoogle Scholar
• Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation115(11), 1464–1480 (2007).
   PubMed Web of Science ®Google Scholar
• Machac J. Cardiac positron emission tomography imaging. SeminNucl. Med.35(1), 17–36 (2005).
   Google Scholar
• Heller GV, Calnon D, Dorbala S. Recent advances in cardiac PET and PET/CT myocardial perfusion imaging. J. Nucl. Cardiol.16(6), 962–969 (2009).
   Google Scholar
• Beller GA, Bergmann SR. Myocardial perfusion imaging agents: SPECT and PET. J. Nucl. Cardiol.11(1), 71–86 (2004).
   Google Scholar
• Yalamanchili P, Wexler E, Hayes M. et al. Mechanism of uptake and retention of F-18 BMS-747158–02 in cardiomyocytes: a novel PET myocardial imaging agent. J. Nucl. Cardiol.14(6), 782–788 (2007).
   Google Scholar
• Bengel FM, Higuchi T, Javadi MS, Lautamaki R. Cardiac positron emission tomography. J. Am. Coll. Cardiol.54(1), 1–15 (2009).
   Google Scholar
• Nandalur KR, Dwamena BA, Choudhri AF, Nandalur SR, Reddy P, Carlos RC. Diagnostic performance of positron emission tomography in the detection of coronary artery disease: a meta-analysis. Acad. Radiol.15(4), 444–451 (2008).
   PubMed Web of Science ®Google Scholar
• Bateman TM, Heller GV, McGhie AI et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J. Nucl. Cardiol.13(1), 24–33 (2006).
   PubMed Web of Science ®Google Scholar
• Yoshinaga K, Chow BJ, Williams K et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J. Am. Coll. Cardiol.48(5), 1029–1039 (2006).
   PubMed Web of Science ®Google Scholar
• Marwick TH, Shan K, Patel S, Go RT, Lauer MS. Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am. J. Cardiol.80(7), 865–870 (1997).
   PubMed Web of Science ®Google Scholar
• Dorbala S, Hachamovitch R, Curillova Z et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc. Imaging2(7), 846–854 (2009).
   PubMed Web of Science ®Google Scholar
• Lertsburapa K, Ahlberg AW, Bateman TM et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J. Nucl. Cardiol.15(6), 745–753 (2008).
   PubMed Web of Science ®Google Scholar
• Schindler TH, Schelbert HR, Quercioli A, Dilsizian L. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc. Imaging3(6), 623–640 (2010).
   PubMed Web of Science ®Google Scholar
• Di Carli MF, Davidson M, Little R et al. Value of metabolic imaging with position emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am. J. Cardiol.73(8), 527–533 (1994).
   PubMed Web of Science ®Google Scholar
• Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr. Prob. Cardiol.32(7), 375–410 (2007).
   PubMed Web of Science ®Google Scholar
• Siebelink HM, Blanksma PK, Crijns HJ et al. No difference in cardiac event-free survival between positron emission tomographyguided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J. Am. Coll. Cardiol37(1), 81–88 (2001).
   PubMed Web of Science ®Google Scholar
• Cerqueira MD. Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: con. J. Nucl. Cardiol.17(4), 683–695 (2010).
   Google Scholar
• Di Carli MF, Hachamovitch R. Hybrid PET/CT is greater than the sum of its parts. J. Nucl. Cardiol.15(1), 118–122 (2008).
   Google Scholar
• Di Carli MF, Dorbala S, Curillova Z et al. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J. Nucl. Cardiol.14(6), 799–809 (2007).
   PubMed Web of Science ®Google Scholar
• Kaufmann PA, Di Carli MF. Hybrid SPECT/CT and PET/CT imaging: the next step in noninvasive cardiac imaging. Semin. Nucl. Med.39(5), 341–347 (2009).
   PubMed Web of Science ®Google Scholar
• Katikireddy CK, McConnell MV. Cardiac MRI and CT. A Practical Approach to Cardiovascular Medicine (First Edition). Blackwell Publishing, Oxford, UK (2011).
   Google Scholar
• Kim HW, Klem I, Kim RJ. Detection of myocardial ischemia by stress perfusion. Cardiovasc. Magn. Reson. Cardiol. Clin.25(1), 57–70 (2007).
   Google Scholar
• Harmon M, Fau G, Nee G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J. Cardiovasc. Magn. Reson.12(1), 29 (2010).
   Google Scholar
• Patel AR, Antkowiak PF, Nandalur KR et al. Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J. Am. Coll. Cardiol.56(7), 561–569 (2010).
   Web of Science ®Google Scholar
• Schwitter J, Wacker CM, Rossum AC et al. MR-IMPACT: comparison of perfusion–cardiac magnetic resonance with single photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur. Heart J.29(4), 480–489 (2008).
   PubMed Web of Science ®Google Scholar
• Paetsch I, Jahnke C, Wahl A et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation110(7), 835–842 (2004).
   PubMed Web of Science ®Google Scholar
• Jahnke C, Nagel E, Gebker R et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation115(13), 1769–1776 (2007).
   PubMed Web of Science ®Google Scholar
• Hendel RC, Patel MR, Kramer CM et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. J. Am. Coll. Cardiol.48(7), 1475–1497 (2006).
   PubMed Web of Science ®Google Scholar
• Raman SV, Dickerson JA, Jekic M et al. Real-time cine and myocardial perfusion with treadmill exercise stress cardiovascular magnetic resonance in patients referred for stress SPECT. J. Cardiovasc. Magn. Reson.12(12), 41 (2010).
   PubMedGoogle Scholar
• Hundley WG, Blumke DA, Finn JP et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol.55(23), 2614–2662 (2010).
   PubMed Web of Science ®Google Scholar
• Jackson E, Bellenger N, Seddon M, Harden S, Peebles C. Ischaemic and non-ischaemic cardiomyopathies cardiac MRI appearances with delayed enhancement. Clin. Radiol.62(5), 395–403 (2007).
   PubMed Web of Science ®Google Scholar
• Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med.343(20), 1445–1453 (2000).
   PubMed Web of Science ®Google Scholar
• Cheong BY, Muthupillai R, Wilson JM et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation120(21), 2069–2076 (2009).
   PubMed Web of Science ®Google Scholar
• Steel K, Broderick R, Gandla V et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation120(14), 1390–1400 (2009).
   PubMed Web of Science ®Google Scholar
• Hachamovitch R. Assessing the prognostic value of cardiovascular imaging: a statistical exercise or a guide to clinical value and application? Circulation120(14), 1342–1344 (2009).
   Google Scholar
• Cho JR, Park S, Choi BW et al. Delayed enhancement magnetic resonance imaging is a significant prognostic factor in patients with non-ischemic cardiomyopathy. Circ J.74(3), 476–483 (2010).
   Google Scholar
• Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation97(8), 765–772 (1998).
   PubMed Web of Science ®Google Scholar
• Bastarrika G, Ramos-Duran L, Schoepf UJ et al. Adenosine-stress dynamic myocardial volume perfusion imaging with second generation dual-source computed tomography: concepts and first experiences. J. Cardiovasc. Comput. Tomogr.4(2), 127–135 (2010).
   Google Scholar
• Mendoza DD, Joshi SB, Weissman G, Taylor AJ, Weigold WG. Viability imaging by cardiac computed tomography. J. Cardiovasc. Comput. Tomogr.4(2), 83–91 (2010).
   Google Scholar
• Taylor AJ, Cerqueira M, Hodgson JM et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. Circulation122(21), e525–e255 (2010).
   Web of Science ®Google Scholar